Whedon M, Ferrell B R
Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.
Semin Oncol Nurs. 1994 Feb;10(1):42-57. doi: 10.1016/s0749-2081(05)80044-0.
Currently, there are more than 2,000 marrow transplant patients surviving between 5 and 20 years. Thus, increased attention is focusing on information about the nature of posttransplant survival and quality of life (QOL). Assessment of the survivor's QOL and rehabilitation needs should consider the domains of physical well-being and symptoms as well as psychological, social, and spiritual well-being. An analysis of the QOL reported in 780 adult survivors from 15 separate studies provides a perspective on the adult BMT survivor beyond the 1-year milestone.
目前，有2000多名骨髓移植患者存活了5至20年。因此，人们越来越关注移植后生存的本质和生活质量（QOL）方面的信息。对幸存者生活质量和康复需求的评估应考虑身体健康和症状领域，以及心理、社会和精神健康领域。对来自15项独立研究的780名成年幸存者报告的生活质量进行分析，为超过1年里程碑的成年骨髓移植幸存者提供了一个视角。
